Current Drug Targets
Title:Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics)
Volume: 15 Issue: 1
Author(s): Jenifer R. Prosperi and Kathleen Heppner Goss
Affiliation:
Export Options
About this article
Cite this article as:
Prosperi R. Jenifer and Goss Heppner Kathleen, Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics), Current Drug Targets 2014; 15 (1) . https://dx.doi.org/10.2174/138945011501140115104533
DOI https://dx.doi.org/10.2174/138945011501140115104533 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
35
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers
Current Cancer Therapy Reviews Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
Current Cancer Drug Targets Structure-Activity Relationships of Multidrug Resistance Reversers
Current Medicinal Chemistry Phage Display Selection and Evaluation of Cancer Drug Targets
Current Cancer Drug Targets Proniosomes in Transdermal Drug Delivery
Current Pharmaceutical Design A Nanostructured Silica-Lipid Hybrid to Facilitate Oral SN-38-based Chemotherapy
Drug Delivery Letters Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance
Recent Patents on Cardiovascular Drug Discovery Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis
Current Topics in Medicinal Chemistry Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines
The Natural Products Journal <i>In vitro</i> and <i>in vivo</i> Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors
Medicinal Chemistry International Conference on Personalized Medicine: “Genes and Medicine” 19-20 September 2009, Hong Kong Science Park, Hong Kong SAR
Current Pharmacogenomics and Personalized Medicine HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research Editorial [Hot Topic: Pancreatic Cancer: Between Bench and Bedside (Guest Editors: Davide Melisi and Alfredo Budillon)]
Current Drug Targets Comprehensive Analysis of Key Proteins Involved in Radioresistance of Prostate Cancer by Integrating Protein-protein Interaction Networks
Current Bioinformatics Sirtuin Family: A Link to Metabolic Signaling and Senescence
Current Medicinal Chemistry Nanobiotechnology and Nanostructured Therapeutic Delivery Systems
Recent Patents on Biomedical Engineering (Discontinued) Oxidative and Non-Oxidative Metabolomics of Ethanol
Current Drug Metabolism New Challenges in Cancer Treatment, from Novel Agents to Innovative Administration
Anti-Cancer Agents in Medicinal Chemistry Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy
Current Pharmaceutical Design